Literature DB >> 10633204

[Assessment of quality of obstetric hospital care: use of corticoid in preterm labor].

L K Silva1, T P Costa, A F Reis, N O Iamada, A P Azevedo, C P Albuquerque.   

Abstract

This study aimed to assess quality of obstetric care for preterm labor patients, using referents, indicators, and standards derived from scientific evidence, focusing on antenatal corticotherapy. Available meta-analyses and randomized controlled trials were examined to establish referents, defining indicators and estimating process and outcome standards for the present study. Data from hospital discharge summaries of seven public maternity hospitals in Rio de Janeiro were analyzed. The standard of process used was 100%. It was not possible to estimate outcome standards, since the necessary adjustment for gestational age was not feasible. Utilization of antenatal corticotherapy in the present study was very low, about 4% and 2%, considering patients up to 33 weeks and 6 days and 36 weeks and 6 days, respectively. Failure to use antenatal corticotherapy when formally indicated deserves attention by health planners and managers, considering: a) the ease in incorporating such a technology, in contrast to the adequate incorporation of special/intensive neonatal care; b) benefits and costs associated with this technology compared to those of delivering neonatal care to premature babies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10633204     DOI: 10.1590/s0102-311x1999000400016

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  2 in total

1.  A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial.

Authors:  Fernando Althabe; José M Belizán; Elizabeth M McClure; Jennifer Hemingway-Foday; Mabel Berrueta; Agustina Mazzoni; Alvaro Ciganda; Shivaprasad S Goudar; Bhalachandra S Kodkany; Niranjana S Mahantshetti; Sangappa M Dhaded; Geetanjali M Katageri; Mrityunjay C Metgud; Anjali M Joshi; Mrutyunjaya B Bellad; Narayan V Honnungar; Richard J Derman; Sarah Saleem; Omrana Pasha; Sumera Ali; Farid Hasnain; Robert L Goldenberg; Fabian Esamai; Paul Nyongesa; Silas Ayunga; Edward A Liechty; Ana L Garces; Lester Figueroa; K Michael Hambidge; Nancy F Krebs; Archana Patel; Anjali Bhandarkar; Manjushri Waikar; Patricia L Hibberd; Elwyn Chomba; Waldemar A Carlo; Angel Mwiche; Melody Chiwila; Albert Manasyan; Sayury Pineda; Sreelatha Meleth; Vanessa Thorsten; Kristen Stolka; Dennis D Wallace; Marion Koso-Thomas; Alan H Jobe; Pierre M Buekens
Journal:  Lancet       Date:  2014-10-15       Impact factor: 79.321

2.  The Antenatal Corticosteroids Trial (ACT)'s explanations for neonatal mortality - a secondary analysis.

Authors:  Fernando Althabe; Vanessa Thorsten; Karen Klein; Elizabeth M McClure; Patricia L Hibberd; Robert L Goldenberg; Waldemar A Carlo; Ana Garces; Archana Patel; Omrana Pasha; Elwyn Chomba; Nancy F Krebs; Shivaprasad Goudar; Richard J Derman; Fabian Esamai; Edward A Liechty; Nellie I Hansen; Sreelatha Meleth; Dennis D Wallace; Marion Koso-Thomas; Alan H Jobe; Pierre M Buekens; José M Belizán
Journal:  Reprod Health       Date:  2016-05-24       Impact factor: 3.223

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.